1-3 of 3
Hugh Grant Prentice
Close
Sort by
Journal Articles

Recognition of Myeloma by MAGE-A3 Specific Cytotoxic T Lymphocytes Induced by Treatment with Azacitidine and MGCD0103

Amberly Moreno-Bost, BS, Susann Szmania, BS, Katie Stone, BS, Jumei Shi, MD, PhD, Tarun K. Garg, PhD, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Hugh Grant Prentice, MD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3674.
https://doi.org/10.1182/blood.V112.11.3674.3674
Published: 2008
Journal Articles

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)

Clinical Trials & Observations
Loı̈c Fouillard, Myriam Labopin, Norbert-Claude Gorin, Emmanuelle Polge, Hugh Grant Prentice, Giovanna Meloni, Josy Reiffers, Arnaud Pigneux, Roel Willemze, Anton Schattenberg, Simona Sica, Monique Lagrange, Odile Fenneteau, Christine Perot, Francesco Frassoni
Journal: Blood
Blood (2002) 100 (9): 3135–3140.
https://doi.org/10.1182/blood.V100.9.3135
Published: 2002
Journal Articles

Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J H -proximal variable gene segments

Forida Y. Mortuza, Ilidia M. Moreira, Maria Papaioannou, Paula Gameiro, Luke A. Coyle, Clair S. Gricks, Peter Amlot, Hugh Grant Prentice, Alejandro Madrigal, Alan Victor Hoffbrand, Letizia Foroni
Journal: Blood
Blood (2001) 97 (9): 2716–2726.
https://doi.org/10.1182/blood.V97.9.2716
Published: 2001